Recognized global leader in plant tissue culture and micropropagation, specializing in providing disease-free, true-to-type plantlets at commercial scale

Key breeder partnerships provide access to extensive portfolio of unique, high value, ready to commercialize, exclusive cultivars

An industry leader in pathogen testing, analysis, surveillance and regeneration; the company is strategically positioned for managing pathogen, virus and viroid threats across the cultivation continuum, from germplasm to live plants

The company operates out of a state-of-the-art, purpose-built tissue culture production and research facility, and a molecular and analytics lab, with a strong focus on the development of intellectual property related to cannabis tissue culture protocols, micropropagation automation, and full-scale production testing from meristem through to flower

The company is built on a diversified revenue platform including differentiated product offerings in plants and seeds, regeneration, genetic banking and analytical detection services

With 2022 revenues of $1M+, a diversified revenue platform, and increasing global sales agreements, the company is currently forecasting approximately $2.5M in revenues for 2023

The company has assembled a world-class science team with expertise navigating cannabis tissue culture, biochemistry, botany, genetic testing, virus assay development, and production under strict regulatory environments

Owner of unique intellectual property in plant tissue culture, molecular plant breeding, and DNA fingerprinting

Experienced domestic and international sales team with extensive expertise navigating the global cannabis markets; currently exporting plants to 5 countries

Operates a small California-based tissue culture lab and currently expanding nursery partnerships in the EU and South Africa

Great opportunity to access a proven global leader in cannabis tissue culture with industry-leading genetics and a global platform to fully support leading edge cannabis cultivation

The company is seeking strategic equity partner to further expand and diversify product programs internationally, target sales growth and commercialize molecular lab